Found "Health Policies": 1,068 results
Sort by
Relevance

Analyses of the return on investment of public health interventions: a scoping review and recommendations for future studies

Abstract Return on investment (ROI) analysis is increasingly being used for evaluating the value for money of public health interventions. Given its potential role for informing health policies, it is important that there is a more comprehensive understanding of ROI analysis within the global

iDSI launches new communication platforms for the global health community

We’re very excited to announce that iDSI has a new and much improved website! We believe that the new site will better serve the global health community: providing access to key resources to support the advancement of healthcare systems and connecting people with our network of health economists and

Investing in Indonesian HTA Champions: HITAP intensifies its efforts

Indonesia established the HTA Committee (HTAC) for deciding the benefits package of the JKN, Indonesia’s universal health coverage (UHC) scheme, and since 2014 HITAP has worked closely with the HTAC to support the development of HTA in the country as part of the International Decision Support Initia

Guest Blog: Reflections from the Training in Singapore and Updates on Philippines HTA

Last January, I had an opportunity to attend a training and symposium entitled ‘Health Technology Assessment: selecting the highest value care’ organized by the Saw Swee Hock School of Public Health, National University of Singapore (NUS), and the Health Intervention and Technology Assessment Progra

A Tribute to Dr. David Banta: the Pioneer of HTA

Since its inception, health technology assessment (HTA) has assisted governments across the world through evidence-informed health resources allocation and it all begins at the Office of Technology Assessment (OTA), United States Congress led by Dr. David Banta.This video is a tribute to Dr. David B

Can AI Really Help Us Prevent Diabetes and Hypertension in Thailand?

Non-communicable diseases (NCDs) are often called “silent killers”, but there is nothing silent about their impact. They remain one of the hardest public health battles to win. According to the World Health Organisation (WHO), they cause 43 million deaths worldwide and account for 75% of non-pandemi

Quality standards for health promotion and disease prevention services in Thailand

1. BackgroundSince 2011 the Ministry of Public Health (MOPH) and the National Health Security Office (NHSO) has collaborated in health promotion and disease prevention program, which aims to provide a high quality of health promotion and disease prevention services for all Thai people. Although the NHSO has indicators for health promotion and disea

Introduction of early health technology assessment for innovators, clinicians, and funders

Abstract Health technology faces rising costs, system complexities, and gaps between development and coverage policies, limiting translation into practice. Traditional health technology assessment (HTA) evaluates technologies at late stages, providing little support if a technology fails to secur

Designing a decision frame for making health resource allocation decisions: a case study in Thailand

The abundance of various innovations in healthcare (pharmaceuticals, medical devices, interventions, individual and community health promotion and disease prevention as well as a social health policy) have been continuously used in the healthcare system, resulting in a higher demand for resources and budgets in disease prevention and healthcare. Th

Health Technology Assessment Development in Lao PDR

Together with the Mahidol Oxford Tropical Medicine Research Unit (MORU), HITAP has been engaged in assisting with building technical capacity for HTA and more broadly, evidence-informed decisions for health care in Laos since 2019. Towards this objective, HITAP hosted researchers from University of Health Sciences (UHS) and Lao-Oxford-Mahosot Hospi
10 / Page